| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/29/2010 | US20100105665 Renin inhibitors |
| 04/29/2010 | US20100105664 Organic compounds |
| 04/29/2010 | US20100105663 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
| 04/29/2010 | US20100105660 Organic compounds75074 |
| 04/29/2010 | US20100105655 Novel compounds 515 |
| 04/29/2010 | US20100105654 Substituted quinazolinone compounds |
| 04/29/2010 | CA2740982A1 Pyridine derivatives substituted with heterocyclic ring and y-glutamylamino group, and antifungal agents containing same |
| 04/29/2010 | CA2739946A1 Isoquinolinone derivatives as nk3 antagonists |
| 04/29/2010 | CA2739915A1 2,5-disubstituted piperidine orexin receptor antagonists |
| 04/28/2010 | EP2180020A1 Indolium compound and optical recording material using the compound |
| 04/28/2010 | EP2179994A1 Fused bicyclic compound |
| 04/28/2010 | EP2178867A1 Process for the production of substituted 5-quinolyl-oxazoles and pharmaceutically acceptable salts thereof |
| 04/28/2010 | EP2178866A2 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 04/28/2010 | EP2178861A2 Heterocyclic amide compounds as protein kinase inhibitors |
| 04/28/2010 | EP2178858A1 Novel heterocyclic compounds as mglu5 antagonists |
| 04/28/2010 | EP2178851A1 Compounds and methods for modulating fxr |
| 04/28/2010 | EP2178840A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 04/28/2010 | EP2178837A2 Isophthalamide derivatives inhibiting beta-secretase activity |
| 04/28/2010 | EP2178835A1 Novel substituted piperidones as hsp inducers |
| 04/28/2010 | EP1881967B1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics |
| 04/28/2010 | EP1720837B1 Derivatives of n-' (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity |
| 04/28/2010 | EP1684750B1 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 04/28/2010 | CN1832939B Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 04/28/2010 | CN1771235B Isoxazole compounds |
| 04/28/2010 | CN1711084B Substituted 4-alkoxyoxazol derivatives as PPAR agonists |
| 04/27/2010 | US7705153 chemokine coupled receptor 3 (CCR3); treating asthma; 1-(heteroarylcarbonyl)-4-piperidino-piperidine compounds |
| 04/27/2010 | US7705151 for treating inflammatory and allergic diseases; 2-methylnicotinic acid derivative is treated with a strong base such as lithium diisopropylamide (LDA) in a suitable solvent such as THF to form the dianion, followed by addition of a nitrile, to provide [1,6]-naphthyridin-5-ol, chlorinating with POCl3 |
| 04/27/2010 | US7705146 inhibitors of the hepatitis C virus NS3 protease; azalactone intermediate reacted with amide anion and decylization; urea or carbamate-terminated alkylglycine, hydroxyproline, cyclopropylglycine tripeptide |
| 04/27/2010 | US7705145 reduction of 4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile to give 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile, hydration of intermediated to form 2-amino-4-methoxy-5-(3-morpholinopropoxy)benzamide; cyclization |
| 04/27/2010 | US7705144 Dyes of improved optical brightness and/or fluorescence and compositions containing them |
| 04/27/2010 | US7705031 Benzimidazoles useful as modulators of ion channels |
| 04/27/2010 | US7705027 Isoxazole compounds as inhibitors of heat shock proteins |
| 04/27/2010 | US7705026 Biaryl heterocyclic compounds and methods of making and using the same |
| 04/27/2010 | US7705024 cannabinoid receptors modulators; metabolic syndrome, obesity, hyperlipidemia, type II diabetes, atherosclerosis, substance addiction, liver cirrhosis, schizophrenia, sexual dysfunction, anxiety; 5-(5-(5-bromoselenophen-2-yl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-3-tert-butyl-1,2,4-oxadiazole |
| 04/27/2010 | US7705020 Benzimidazolone carboxylic acid derivatives |
| 04/27/2010 | US7705009 4-aminopyrimidine-5-thione derivatives |
| 04/27/2010 | US7705007 Cis-imidazolines |
| 04/27/2010 | US7704998 Sulfonyl-derivatives as novel inhibitors or histone deacetylase |
| 04/27/2010 | US7704997 Amino-tetrazole analogues and methods of use |
| 04/27/2010 | US7704995 Protein kinase modulators and methods of use |
| 04/27/2010 | US7704994 1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3- pyridinyl}-2-pyrrolidinone and salts; histamine H3 antagonists; Alzheimer's disease; schizophrena; antiepileptic agents; analgesics; neuropathic pain; Parkinson's disease; attention deficit disorder |
| 04/27/2010 | CA2563042C 4-2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases |
| 04/27/2010 | CA2551038C Triazole derivatives as vasopressin antagonists |
| 04/27/2010 | CA2493667C Vanilloid receptor ligands and their use in treatments |
| 04/27/2010 | CA2449180C Viral polymerase inhibitors |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2394848C 3-(4,5-dihydroisoxazole-5-yl)benzoylpyrazole |
| 04/27/2010 | CA2354213C N-triazolylmethyl-piperazine compounds with neurokinin-receptor antagonist activity |
| 04/22/2010 | WO2010045188A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | WO2010045166A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/22/2010 | WO2010043396A1 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| 04/22/2010 | WO2010043315A1 Pesticidal (hetero) arylpyrrolidines |
| 04/22/2010 | WO2010043000A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | WO2010042998A1 S1p receptors modulators |
| 04/22/2010 | WO2009158309A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 04/22/2010 | WO2009068468A3 Pyridine compounds |
| 04/22/2010 | US20100099716 Cetp inhibitors |
| 04/22/2010 | US20100099689 Methods of modulating ppar gamma-type receptors |
| 04/22/2010 | US20100099676 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 04/22/2010 | US20100099675 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 04/22/2010 | US20100099674 Method and means for preventing and inhibiting type iii secretion in infections caused by gram-negative bacteria |
| 04/22/2010 | US20100099673 Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| 04/22/2010 | US20100099670 Benzoquinazoline derivatives |
| 04/22/2010 | US20100099667 Bridged heterocyclic compounds and methods of use |
| 04/22/2010 | US20100099659 Inhibitors of Bruton's Tyrosine Kinase |
| 04/22/2010 | US20100099658 Di(arylamino)aryl compound |
| 04/22/2010 | US20100099561 Heterobicyclic alkylthio-bridged isoxazolines |
| 04/22/2010 | CA2740696A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/22/2010 | CA2740608A1 Pesticidal (hetero) arylpyrrolidines |
| 04/22/2010 | CA2740484A1 S1p receptors modulators and their use thereof |
| 04/22/2010 | CA2739901A1 S1p receptors modulators |
| 04/22/2010 | CA2738929A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2738849A1 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| 04/21/2010 | EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors |
| 04/21/2010 | EP2177518A1 Organic compounds |
| 04/21/2010 | EP2176257A2 Hydrogen chloride salt of a substituted 5-oxazol-2-yl-quinoline compound and a process for the production thereof |
| 04/21/2010 | EP2176256A2 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 04/21/2010 | EP2176251A2 5-pyridinone substituted indazoles |
| 04/21/2010 | EP2176249A2 New chemical compounds |
| 04/21/2010 | EP2176223A1 Malonamide derivatives with antithrombotic activity |
| 04/21/2010 | EP1887005B1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof |
| 04/21/2010 | EP1761494B1 Chemical compounds i |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | CN1854134B Piperazine compounds, their preparation method and pharmaceutical composition containing same |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/20/2010 | US7700778 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/20/2010 | US7700771 antiinflammatory agents; antiarthritic agents |
| 04/20/2010 | US7700637 Organic compounds |
| 04/20/2010 | US7700634 (Indol-3-yl) heterocycle derivatives as agonists of the cannabinoid CB1 receptor |
| 04/20/2010 | US7700630 3-Quinolin-2-ylmethylene-3,4,5,6-terahydro[2,3']bipyridinyl; for therapy and prophylaxis of psychotic diseases, neurodegenerative diseases involving a dysfunction of the cholinergic system |
| 04/20/2010 | US7700628 Aromatic ether derivatives useful as thrombin inhibitors |
| 04/20/2010 | US7700622 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents |
| 04/20/2010 | US7700621 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 04/20/2010 | US7700595 such as 3-benzyl-4-phenyl-8-(trifluoromethyl)cinnoline; modulators of Liver X receptors (LXRs) |
| 04/20/2010 | US7700591 to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 04/20/2010 | US7700552 Macrocyclic inhibitors of hepatitis C virus |
| 04/20/2010 | CA2581865C Indazolone derivatives as 11b-hsd1 inhibitors |
| 04/20/2010 | CA2510540C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/20/2010 | CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 04/20/2010 | CA2454485C Arthropodicidal anthranilamides |